Maximum Strength Pepcid AC launch
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson/Merck celebrates launch of its new H2 blocker with Claud Mann, chef and co-host of Dinner & a Movie, J&J announces Oct. 24. The event, which was hosted at the New York Culinary Loft, focused on preparing meals that are less heartburn-inducing. New 20 mg famotidine tablet is twice the strength of the original Pepcid AC. Shipments began immediately following FDA approval of the dosage in late September (1"The Tan Sheet" Sept. 29, 2003, p. 3)...
You may also be interested in...
J&J/Merck Bolsters Heartburn Lineup With Maximum Strength Pepcid AC
New heartburn prevention/relief product Maximum Strength Pepcid AC will hit shelves Oct. 17, following FDA approval of the new dosage Sept. 24, according to Johnson & Johnson/Merck
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.